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Abstract  The  treatment  of  patients  with  a  malignant  rectal  tumor  has  evolved  over  the  past
few years.  The  role  of  medical  imaging  techniques,  notably  MRI,  has  become  increasingly  impor-
tant in  the  preoperative  assessment  of  rectal  tumors.  Radiologists  are  ﬁnding  that  their  presence
is requested  more  and  more  frequently  at  multidisciplinary  team  meetings  for  decision-making
on the  treatment  of  these  tumors  and  therefore  they  must  have  a  grounding  in  the  therapeutic
issues involved.  Locoregional  assessment  of  malignant  rectal  tumors  may  be  performed  prior  to
initiating  treatment  or  as  a  re-evaluation  following  neoadjuvant  therapy.  We  are  interested  in
the assessment  of  the  initial  locoregional  extension  of  these  rectal  tumors  and  we  place  much
emphasis on  the  ability  to  identify  MRI  criteria  which  determine  the  patient’s  prognosis  and
treatment.  We  will  also  examine  the  advantages  of  MRI  as  well  as  its  limits  in  this  assessment.
© 2014  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
During  the  past  decades,  the  management  of  patients  with  rectal  cancer  has  evolved  with
a  signiﬁcant  reduction  in  local  recurrence  rate  due  to  advances  in  surgical  techniques  and
adjuvant  therapies.  Radiologist  is  now  part  of  the  decision-making  process  during  multi-
disciplinary  team  meetings,  both  giving  an  anatomic  deﬁnition  of  the  tumor  for  surgical
planning  and  differentiating  between  good  and  bad  prognosis  tumors.  This  review  explains
the  role  of  the  radiologist  in  patient  management  and  describes  the  clinically  relevant
points  radiologists  have  to  notify  during  primary  local  staging  of  rectal  cancer  patients.  It
also  gives  the  evidence  for  the  use  of  magnetic  resonance  imaging  (MRI)  in  staging  these
patients,  reviews  MRI  performances  in  identifying  several  clinically  relevant  features,  and
gives  some  recommendations  for  how  to  perform  rectal  MR  examinations.
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ocal staging modalities
he  two  imaging  modalities  that  are  currently  being  used  for
ocal  rectal  tumor  staging  are  endorectal  ultrasonography
ERUS)  and  magnetic  resonance  imaging  (MRI).
RUS
nlike  with  MRI,  using  ERUS,  all  layers  of  the  bowel  wall
an  be  examined,  with  high  accuracies  reported  for  T  stag-
ng  [1].  True  performances  of  ERUS  are  difﬁcult  to  evaluate
ecause  in  many  initial  studies,  the  patients  with  stenos-
ng  tumors  were  excluded.  However,  it  is  well  admitted  that
RUS  remains  the  imaging  method  of  ﬁrst  choice  for  dif-
erentiating  between  T1  and  T2  tumors  and  also  for  the
ssessment  of  T1  tumors  before  local  excision,  but  that  it
erforms  less  well  in  cases  of  advanced  and  polypoid  lesions
2,3].  The  fascia  recti  and  peritoneum  cannot  be  correctly
isualized  by  ERUS  so  that  the  circumferential  resection
argin  (CRM)  status  and  degree  of  peritoneal  involvement
annot  be  assessed  accurately  (Fig.  1).
As  far  as  T2  versus  T3  tumors  differentiation  is  con-
erned,  although  sensitivity  of  ERUS  (90—96%)  is  high,
peciﬁcity  is  lower  (75—90.6%)  [1,2,4],  respectively,  with
he  same  difﬁculties  as  those  observed  with  MRI  to  discrim-
nate  between  T2  and  small  T3  tumors  and  interpret  T2
ith  desmoplastic  stranding  in  the  mesorectal  fat.  For  lymph
ode  involvement,  results  are  comparable  to  those  obtained
ith  MRI  [1,2].
Further  downside  of  ERUS  is  that  it  is  subject  to  opera-
or’s  skill  and  that  surgeons  or  radiotherapists  cannot  read
he  images  as  easily  as  with  MRI  or  CT.
The  use  of  endorectal  ultrasonography  is  variable
hroughout  Europe,  with  Holland  being  one  of  the  countries
here  it  is  least  widely  used.  In  France,  its  use  depends  on
ts  availability  and  on  the  preferences  of  oncologists,  but
ecommendations  still  advise  ERUS  as  a  ﬁrst-step  imaging
odality  for  local  staging  of  rectal  cancer,  when  the  tumor
s  not  bulky  and/or  located  in  the  upper  rectum  and/or  ﬁxed.
igure 1. Endorectal ultrasonography (ERUS) image of T3 rectal
umor (arrows). Note the small ﬁeld of view of the ERUS image.
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RI
 group  of  14  abdominal  imaging  experts  from  the  Euro-
ean  Society  of  Gastrointestinal  and  Abdominal  Radiology
ESGAR)  in  a  recent  article  [5], as  well  as  ESMO  clinical
ractice  guidelines  [6]  and  European  rectal  cancer  consen-
us  conference  [7]  recommend  MRI  as  crucial  for  staging  the
rimary  rectal  cancer.  Beets-Tan  et  al.  [5]  further  report
 consensus  reached  by  the  panel  of  European  experts  that
RI  is  the  imaging  technique  of  ﬁrst  choice  for  primary  stag-
ng  of  rectal  cancer  but  that  ERUS  remains  the  ﬁrst  choice
maging  modality  when  local  resection  is  being  considered.
In  a  recent  meta-analysis  including  21  studies  from  2000
o  2011  excluding  patients  who  underwent  preoperative
ong-course  radiotherapy  or  chemoradiotherapy,  Al-Sukhni
t  al.  [8]  found  a  good  accuracy  of  MRI  for  both  CRM  and  T
ategory  (sensitivities  and  speciﬁcities  of  77%  [57—90%;  95%
I]  and  94%  [88—97%;  95%  CI]  for  CRM  —  87%  [81—92%;  95%
I]  and  75%  [68—80%;  95%  CI]  for  T,  respectively).  In  contrast
o  its  performance  for  T  category  and  CRM,  MRI  performance
as  more  consistently  poor  for  the  assessment  of  lymph  node
etastases.
RI protocol
ome  teams  use  spasmolytic  agents  (e.g.  Buscopan  or
lucagon).  Routine  rectal  ﬁlling,  predominantly  with  ultra-
onography  gel,  is  still  a  matter  of  debate.  It  allows  better
elineation  of  the  lower  pole  of  the  tumor,  particularly
or  readers  with  less  experience  and  reduces  artifacts  on
iffusion-weighted  acquisitions.  Conversely,  it  may  com-
ress  the  mesorectal  fat  and  hamper  evaluation  of  CRM  [9]
nd  may  be  uncomfortable  to  the  patient.
The  importance  of  rectal  cancer  MRI  protocols  on  inter-
retation  accuracy  has  been  reported  [10],  particularly  in
erms  of  accuracy  regarding  assessment  of  anterior  organ
nvolvement  for  low  rectal  tumors.  MR  protocol  includes
D  T2-weighted  sequences  acquired  in  sagittal,  axial  and
blique  planes,  with  the  sagittal  sequence  being  used  to
etermine  the  longitudinal  tumor  axis  in  order  to  angle  the
xial  and  coronal  planes  as  perpendicular  and  parallel  to
he  tumor  axis,  respectively.  Incorrect  plane  obliquity  leads
o  blurring  of  the  muscularis  propria  or  to  a  pseudospic-
lated  appearance.  For  low  rectal  tumors,  coronal  planes
hould  also  be  angled  parallel  to  the  anal  canal  in  order
o  better  evaluate  relationship  between  the  tumor  and  the
nal  sphincter  [11]. Three-dimensional  (3D)  T2-weighted
equences  permit  the  use  of  1—2  mm  thin  sections  with  no
ntersection  gap.  They  are  theoretically  able  to  compensate
or  difﬁculties  to  angulation  of  tumor  such  as  tortuosity  and
edundancy  of  the  rectum.  However,  evidence  with  respect
o  their  superiority  compared  to  2D  T2-weighted  sequences
s  still  lacking  with  contradictory  results  mainly  in  terms  of
ontrast  resolution  and  tumor  conspicuity,  due  to  many  fac-
ors  such  as  the  type  of  MR  unit  used,  section  thickness  and
se  of  parallel  imaging  [12—14]  (Fig.  2).  Moreover,  multi-
lanar  reformatted  images  obtained  away  from  the  plane  of
cquisition  are  frequently  blurred  and  small-FOV  images  are
ifﬁcult  to  obtain.
As  far  as  diffusion-weighted  imaging  is  concerned,
lthough  more  and  more  authors  use  it  to  improve  the
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tumors,  i.e.  without  any  neoadjuvant  chemoradiotherapyFigure 2. Coronal 2D T2-weighted MR image (a) shows better cons
3D T2-weighted MR image acquired in the same patient at the same
diagnostic  performance  of  MRI  for  the  evaluation  of  tumoral
response  after  chemoradiotherapy,  there  is  so  far  no
evidence  that  it  is  of  some  help  for  primary  staging  apart
from  improving  tumoral  and  lymph  node  detection  [5,15]
(Fig.  3).  They  are  thus  not  recommended  for  primary
staging.  In  the  consensus  paper  [5],  the  use  of  additional
unenhanced  T1-weighted  sequence  to  T2-weighted  FSE
was  supported  by  only  25%  of  the  panelists,  mainly  for
the  help  that  it  may  provide  characterizing  coincidental
pelvic  ﬁndings.  The  authors  did  not  either  recommend
the  use  of  contrast-enhanced  dynamic  or  steady  state
T1-weighted  sequences,  relying  on  their  experience  and
on  the  lack  of  available  evidence  supporting  the  adjunct  of
contrast-enhanced  sequences  [5,16].  Some  teams,  mainly
in  France,  somehow  use  fat-suppressed  MR  sequences
in  order  to  facilitate  assessment  of  relationships  of  a
low  rectal  tumor  to  the  anal  sphincters,  particularly  to
the  internal  sphincter  that  enhances  after  gadolinium
administration.
u
o
t
Figure 3. Axial high b value (b = 1000) diffusion-weighted MR image 
depicted on the corresponding T2-weighted MR image (b) (arrows).ty of the tumor and of its extension in the mesorectum than coronal
e (b) (arrows).
R image interpretation
ocation of the tumor
etection  of  rectal  tumor  relies  on  clinical  examination
nd/or  endoscopy.  The  tumor  is  generally  detected  and
ocated  during  digital  rectal  examination  but  may  remain
ifﬁcult  to  feel  and/or  locate  for  the  physician,  particularly
n  case  of  upper  rectal  tumors.  Rectal  tumor  is  most  often
ell  depicted  on  T2-weighted  MR  images.
There  are  different  means  of  determining  the  height  of
he  tumor.  Rectal  tumor  level  can  be  given  with  respect
o  its  peritoneal  or  subperitoneal  location,  knowing  that
umors  located  entirely  above  the  peritoneal  reﬂection,  i.e.
pper  rectal  tumor,  will  generally  be  treated  like  colonicnless  they  are  considered  T4  tumors.  The  anterior  wall
f  the  upper  rectum  is  covered  by  the  peritoneal  reﬂec-
ion  and  the  point  of  peritoneal  attachment  occurs  at  a
(a) increases detection of the low rectum tumor which is hardly
4 C.  Hoeffel  et  al.
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ariable  height,  particularly  in  women.  In  Gollub  et  al.’s
tudy  [17],  median  distances  from  the  anorectal  junction
o  the  anterior  peritoneal  reﬂection  was  67  to  69  mm  (range
1—128  mm,  35—130  mm)  and  the  average  length  of  the  anal
anal  was  41  and  36  mm  for  women.  Both  readers  analyzing
R  images  indicated  that  the  anterior  peritoneal  reﬂection
as  ‘‘probably’’  or  ‘‘deﬁnitely’’  visible  in  134  of  180  pelvic
R  examinations  (74.4%),  as  a  thin  T2  hypointense  line  1  mm
r  less  in  thickness  in  most  cases,  in  the  midsagittal  plane.
natomic  landmarks  for  identiﬁcation  of  the  most  inferior
ortion  of  the  peritoneal  membrane  were  tip  of  seminal  vesi-
les  in  men  and  the  uterocervical  angle  in  women  (Fig.  4).
imitations  for  identiﬁcation  of  this  line  included  postop-
rative  status,  motion  artifact,  retroversion  of  the  uterus,
aucity  of  pelvic  fat  planes  or  large  exophytic  tumors.  As
he  peritoneal  reﬂection  proceeds  posteriorly,  laterally  and
uperiorly  towards  the  anterior  portion  of  the  rectum,  it  is
oteworthy  that  the  peritoneal  reﬂection  will  appear  higher
f  visualized  off  midline.
The  level  of  the  rectal  tumor  may  also  be  given  from
he  anal  verge,  which  is  the  distal  end  of  the  anal  canal,
s  it  is  a  reference  point  for  physicians  (Fig.  5).  According
o  this  reference,  the  rectum  is  divided  into  three  thirds.
umors  of  the  lower  third  have  a  lowest  edge,  which  is
ocated  less  than  5  cm  from  the  anal  verge.  It  corresponds
o  the  level  where  mesorectum  tapers  sharply  (Fig.  6).  The
norectal  junction  is  held  forward  by  the  puborectal  sling.
he  anorectal  junction  is  an  important  landmark  and  it  is
een  as  transition  from  low  T2  signal  (the  superior  border  of
he  internal  sphincter  and  the  puborectalis  complex  =  upper
dge  of  the  surgical  anal  canal)  to  intermediate  T2  signal
rectal  wall)  (Fig.  7).  It  is  the  point  where  the  internal  layer
f  the  muscularis  propria  thickens  and  becomes  the  inter-
al  sphincter.  The  external  sphincter  complex  is  composed
f  the  puborectalis  sling  and  then  caudally  of  the  external
phincter.  Between  these  two  sphincters,  there  is  a  plane
alled  the  intersphincteric  plane.Tumors  are  considered  in  the  middle  rectum  if  their  low-
st  edge  is  located  between  5  and  10  cm  from  the  anal
erge.  At  this  level,  the  rectum  is  surrounded  by  mesorec-
um,  itself  limited  by  mesorectal  fascia,  forming  the  surgical
O
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igure 4. Anterior peritoneal reﬂection is well seen on sagittal T2-we
n axial T2-weighted MR image (b), mimicking a seagull (arrows).igure 5. The height of the tumor is given from the anal verge,
s it is a useful reference point for the surgeons.
lane  of  dissection  for  total  mesorectal  excision.  Anteriorly
he  mesorectal  fascia  fuses  caudally  with  the  remnant  of  the
rogenital  septum  forming  a  dense  fascia  band  called  recto-
aginal  septum  in  females  and  rectoprostatic  fascia  in  men.
pper  rectal  tumors  are  located  more  than  10  cm  from  the
nal  verge,  above  the  inferior  point  of  the  peritoneal  reﬂec-
ion.  Level  of  the  tumor  may  also  be  given  with  respect  to
he  upper  pole  of  the  internal  sphincter.
 staging and depth of tumor spread beyond
he muscularis proprian  T2-weighted  images,  stage  T1  tumors  are  conﬁned  to
he  submucosa,  which  manifests  as  a  hyperintense  layer;
tage  T2  tumors  extend  into,  but  not  beyond,  the  muscu-
aris  propria,  which  is  seen  as  a  hypointense  layer;  and  stage
ighted MR image (a), at the tip of the seminal vesicles, as well as
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conventional  staging  systems  are  insufﬁcient  in  these  cases,Figure 6. The upper part of the low rectum corresponds to the
area where the mesorectum tapers sharply (arrows).
T3  tumors  extend  beyond  the  muscularis  propria  into  the
mesorectal  fat  [18].  T4  disease  corresponds  to  spread  of
tumor  into  the  visceral  peritoneum  (T4a)  (Fig.  8)  or  adjacent
organs  (T4b).  The  structures  most  commonly  involved  by  pri-
mary  rectal  cancer  are  the  uterus,  vagina,  prostate  gland
and  seminal  vesicles.  The  assessment  of  tumor  abutment  of
the  presacral  fascia  and  involvement  of  sacral  nerve  roots  is
also  important  for  surgical  planning  as  tumor  extension  into
the  proximal  sacrum  or  nerve  root  involvement  above  the
S2  vertebral  level  renders  the  tumor  unresectable.
The  relationship  between  tumor  and  the  peritoneal
reﬂection  is  important  to  assess  in  order  to  warn  the  sur-
geon  to  perform  careful  dissection  to  minimize  the  risk  of
tumor  spillage  in  case  of  T4  a  tumor.
T  stage  assessment  depends  of  course  on  optimiza-
tion  of  the  MRI  protocol  but  also  on  the  experience  of
the  reader  [19].  It  is  known  to  be  difﬁcult  to  distinguish
between  T2  and  small  T3  tumors,  particularly  to  differen-
tiate  between  desmoplastic  reaction  and  true  mesorectal
invasion,  although  the  latter  is  known  to  form  intermediate
b
t
p
Figure 7. Sagittal (a), coronal (b) and axial (c) T2-weighted MR image
landmark and corresponds to the transitional zone between the superior 
the rectal wall. It is the point where the internal layer of the muscularisigure 8. Sagittal T2-weighted MR image shows extension of the
ectal tumor to the anterior peritoneal reﬂection (arrow).
ignal  intensity  linear  bands,  thicker  than  what  is  usually
een  with  desmoplasia.
However,  it  is  much  more  important  to  measure  the  depth
f  extramural  spread  in  the  mesorectal  fat  than  to  give
he  T  stage,  since  a  T2  tumor  has  the  same  prognosis  as
 T3  tumor  with  less  than  1  mm  spread.  T3  tumors  with
ore  than  5  mm  mesorectal  invasion  (Fig.  9)  have  a  can-
er  speciﬁc  5-year  survival  rate  of  approximately  54%  versus
5%  for  tumors  with  less  than  5  mm  mesorectal  invasion
20,21]  (Fig.  10).  The  depth  of  extramural  spread  must  be
easured  in  millimeters  beyond  the  outer  edge  of  the  longi-
udinal  muscular  layer  and  recorded  according  to  Smith  and
rown  [21]. The  MERCURY  Study  Group  showed  that  there
as  excellent  correlation  between  the  depth  of  extramural
pread  and  histopathologic  results  [22].
Low  rectal  tumors  deserve  special  consideration  becauseecause  anatomy  is  different  than  for  mid-  and  upper  rec-
um  and  because  three  different  types  of  surgery  can  be
erformed  depending  on  tumoral  stage  [23].
s showing the level of the anorectal junction which is an important
border of the internal sphincter plus the puborectalis complex and
 propria thickens and becomes the internal sphincter (arrows).
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Figure 9. Axial T2-weighted MR image showing a T3 tumor with
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continuity  is  not  maintained.  This  applies  to  tumors  extend-
ing  into  the  internal  sphincter  (partial  invasion)  but  not
extending  to  the  full  thickness  of  muscularis  propria  or  to
the  intersphincteric  plane  or  beyond.
Lastly,  in  case  of  low  rectal  tumors  extending  within  1  mm
of  circumferential  resection  margin  or  in  the  intersphinc-
teric  plane  (Fig.  11) and/or  extending  into  or  beyond  the
levator  muscles,  extralevator  abdominoperineal  excision  is
performed:  the  abdominal  part  of  surgery  follows  the  plane
of  total  mesorectal  excision  (TME)  dissection,  as  described
above,  but  mobilisation  is  stopped  at  the  upper  border  [11].
Recently,  Shihab  et  al.  [11,24]  proposed  a speciﬁc  T  staging
for  low  rectal  tumors  to  better  deﬁne  the  tumor  free  margin.
This  staging  is  based  on  the  coronal  and  axial  T2-weighted
images  and  includes  precise  assessment  of  the  involvement
of  muscularis  propria,  of  the  intersphincteric  plane  and  of
the  external  sphincter.
Assessment of circumferential resection
margin (CRM)
Identiﬁcation  of  tumors  with  a  potentially  positive  CRM  by
MRI  is  necessary  for  aggressive  preoperative  treatment  and
prevention  of  local  recurrence  [25]  (Fig.  12).
A  recent  prospective  multicenter  study  consisting  of
follow-up  of  374  patients  with  rectal  cancer  assessed  with
MRI,  of  which  216  (57.8%)  underwent  primary  surgery,  con-
ﬁrms  that  MRI  assessment  of  CRM  status  is  superior  to
TNM-based  criteria  for  assessing  risk  of  local  recurrence,
disease-free  survival  and  overall  survival.  Interestingly,  it
also  demonstrates  that  CRM  involvement  is  signiﬁcantly
associated  with  distant  metastatic  disease.  When  correlated
with  pathologic  specimens,  it  has  been  shown  that  the  risk
of  local  recurrence  is  signiﬁcantly  increased  with  clearancesetween 5—10 mm extension in the mesorectal fat (arrow). Note
he vicinity of a tumoral deposit to the rectal fascia.
In  case  of  low  rectal  tumor  without  any  sphincter  invasion
and  a  distance  between  its  inferior  pole  and  the  upper  pole
f  the  internal  sphincter),  low  anterior  resection  consisting
f  an  en  bloc  resection  of  the  rectum  as  well  as  of  total
esorectal  excision  may  be  performed.  To  produce  unin-
olved  margins,  the  tumor  must  not  extend  to  ≥1  mm  of
ircumferential  resection  margin  (mesorectal  fascia  or  leva-
or  ani  muscle  for  tumor  located  just  above  the  puborectal
ling).This  plane  can  be  further  extended  distally  to  perform
n  intersphincteric  abdominoperineal  excision—–essentially
he  same  plane  as  low  anterior  resection,  but  intestinal
igure 10. Axial T2-weighted MR image showing a T3 tumor with
 mm extension in the mesorectal fat (arrow).
Figure 11. Axial T2-weighed MR image showing a tumor in the
anal canal invading the full thickness of the internal sphincter apart
in some parts (arrowhead) as well as the intersphincteric plane, in
close contact to the external sphincter (arrows). An abdominoper-
ineal resection is necessary.
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Figure 12. Axial T2-weighted MR image shows a T3 tumor with
Figure 13. Axial T2-weighted MR image showing an extramural
v
i
o
h
s
l
T
m
i
l
r
m
f
l
M
m
v
a
s
r
d
a
f
n
c
y
h
a
c
t
aan extension in close contact to the mesorectal fascia (arrow). Cir-
cumferential resection margin is thus positive.
of  1  mm  or  less,  which  are  thus  considered  a  positive  CRM
[26].  Using  this  1  mm  cut-off,  speciﬁcity  and  negative  pre-
dictive  values  are  of  92  and  94%,  respectively,  for  predicting
involvement  of  the  CRM  by  MRI  [8,27].  The  measured  dis-
tance  is  the  distance  to  the  mesorectal  fascia  and/or  to  the
levator  ani  muscles  for  low  rectal  tumors  from  either  the
tumor  margin,  tumor  thrombus  within  a  vessel,  malignant
node  or  tumor  deposit.  Limitations  of  assessment  of  the  CRM
include  patients  with  low  and  anterior  rectal  tumors  and  thin
patients  with  little  perirectal  fat.
Extramuscular vascular invasion (EMVI)
EMVI  is  invasion  of  large  vessels  directly  by  tumor,  which
are  located  deep  to  the  muscularis  propria.  The  presence  of
tumor  signal  intensity  within  an  expanded  vascular  struc-
ture  is  highly  suggestive  of  extramural  vascular  invasion
(Fig.  13).  The  possibility  of  EMVI  should  be  considered  when-
ever  tumor  is  seen  to  lie  close  to  a  vessel  [28].  EMVI  is
considered  by  some  authors  as  an  important  prognostic  fac-
tor  that  should  be  identiﬁed  on  MRI  [29,30].  A  recent  study
[31]  even  reported  that  patients  who  presented  a  signiﬁcant
response  of  EMVI  to  neoadjuvant  chemoradiation  therapy
showed  improved  disease-free  survival.
Nodal staging
Nodal  spread  occurs  via  the  mesorectal  lymph  nodes  and
along  the  superior  rectal  vessels  as  well  as  laterally  along
the  internal  and  external  iliac  chains.  They  are  typically
at  the  level  of  the  primary  tumor  or  above.  External  iliac
lymph  nodes  and  obturator  lymph  nodes  are  consistent  with
metastases.  Size  criteria  that  are  used  to  detect  lymph  node
involvement  are  insufﬁcient,  as  using  a  5  mm  short  axis  as  a
cut-off  has  proven  to  provide  a  sensitivity  of  66%  and  a  speci-
ﬁcity  of  76%  [32].  Morphological  criteria  such  as  irregularity
P
T
pascular invasion seen as an expanded vessel with tumoral signal
ntensity inside (arrows).
f  the  contours  and  heterogeneous  internal  signal  intensity
ave  been  evaluated  and  better  predict  involvement  than
ize  alone  [32,33].  Patients  with  4  or  more  involved  regional
ymph  nodes  are  known  to  have  a  worse  prognosis  [34].
hese  patients  are  somehow  likely  to  present  with  other
ore  easily  recognizable  poor  prognosis  MR  features  such  as
mportant  depth  of  extramural  spread  or  CRM  involvement.
It  is  also  important  to  identify  involved  lymph  nodes
ocated  outside  mesorectal  fascia,  as  they  will  not  be
esected  during  standard  anterior  resection  with  total
esorectal  excision  and  may  for  some  authors  beneﬁciate
rom  additional  treatment,  as  they  may  be  responsible  for
ocal  recurrence.
A  recent  study  that  matched  lymph  nodes  seen  on
RI  with  their  precise  histologic  counterparts  after  total
esorectal  excision  reported  that  of  the  341  nodes  har-
ested,  120  were  too  small  (<3  mm)  to  be  depicted  with  MRI,
nd  15%  of  these  contained  metastases,  with  a  node-by-node
ensitivity  and  positive  predictive  value  of  58  and  61.7%,
espectively  [35]. Moreover,  there  was  no  difference  in  the
iagnostic  accuracy  between  the  primary  surgery  subgroup
nd  preoperative  radiation  subgroups.  Given  the  low  per-
ormances  of  conventional  criteria  for  assessment  of  lymph
ode  status,  the  use  of  superparamagnetic  iron  oxide  parti-
les  [36,37]  or  Gadofosveset  [38]  has  been  evaluated  and
ielded  promising  results.  However,  these  speciﬁc  agents
ave  been  withdrawn  for  the  market  and  are  currently  not
vailable.  As  far  as  diffusion-weighted  MR  imaging  is  con-
erned,  it  has  been  proved  that  although  it  improves  detec-
ion  of  lymph  nodes,  it  cannot  help  to  accurately  differenti-
te  between  benign  and  malignant  lymph  node  [39]  (Fig.  14).rognostic risk factors
here  is  a  current  trend  to  use  MRI  for  identiﬁcation  of
rognostic  risk  factors,  thereby  potentially  allowing  the
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Figure 14. Sagittal T2-weighted MR image showing some suspi-
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1ious lymph nodes (arrows). One must record the location, number,
ite of the lymph nodes and if there are any suspicious morphological
eatures such as heterogeneity or irregular contours.
election  of  low  risk  patients  whose  indication  is  primary
urgery  and  the  high-risk  patients  who  will  beneﬁt  from
ntensiﬁed  neoadjuvant  treatment  [40].  Stratiﬁcation  of
atients  include  mainly  determination  of  the  depth  of  tumor
pread  beyond  the  muscularis  propria,  EMVI,  CRM,  but  also
ocation  of  the  tumor,  nodal  status,  and  presence  of  periton-
al  perforation.  The  latest  and  seventh  edition  of  the  TNM
as  made  changes  based  on  recurrence  and  survival  data.
Good  prognosis  patients  are  those  whose  tumor  has  a
RM  >1  mm,  T1—T2  or  T3  tumors  with  extramural  extension
5  mm,  absence  of  extramural  vascular  invasion,  N0/N1,
umors  located  in  the  middle  or  upper  third  [29,41—44].
he  Mercury  Study  Group  [42]  in  a  prospective  and  multi-
enter  study  reported  that  for  patients  who  were  considered
o  have  a  good  prognosis  on  the  basis  of  a  potentially  nega-
ive  CRM  (>1  mm  of  the  mesorectal  fascia),  of  absence  of
xtramural  invasion,  of  tumors  staged  T1,  T2  or  T3  with
xtramural  extension  <5  mm  and  low  rectal  tumors  not  com-
romising  the  intersphincteric  space  or  levator  ani  muscles,
hatever  the  N  stage,  overall  survival  and  disease-free
urvival  were  68  and  85%,  respectively  and  local  recur-
ence  rate  was  of  3%.  Conversely,  poor  prognosis  tumors
nclude  tumors  with  potentially  positive  CRM,  a  committed
ntersphincteric  space,  an  extramural  extension  >5  mm  and
resence  of  extramural  vascular  invasion.
onclusion
ndorectal  ultrasonography  and  pelvic  MR  imaging  are  the
wo  main  imaging  modalities  for  preoperative  assessment
f  rectal  tumor.  Preoperative  MR  imaging  of  rectal  cancer  is
ow  well  deﬁned  and  is  part  of  the  multidisciplinary  team
iscussion.  Preoperative  MR  imaging  of  rectal  cancer  implies
ptimization  of  MR  technique  and  sequence  parameters  as
ell  as  familiarity  of  the  reader  with  anatomy,  limitationsC.  Hoeffel  et  al.
f  the  technique  and  understanding  of  how  preoperative
maging  impacts  the  management  of  the  patient.  Some  key
oints  that  are  not  currently  part  of  the  TNM  staging  should
omehow  be  incorporated  into  all  reports  for  prognostic
mplications.
TAKE-HOME  MESSAGES
• A  pelvic  MRI  provides  the  elements  required  for
the  assessment  of  locoregional  extension  of  a  rectal
tumor  as  well  as  prognostic  elements.
• An  endorectal  ultrasound  is  the  preferred  medical
imaging  technique  for  differentiating  T1  and  T2
tumors.
• T2-weighted  sequences  without  fat  suppression  in
the  three  planes  and  perpendicular  to  the  axis  of  the
tumor  are  essential  and  are  generally  sufﬁcient.
• Sections  on  the  tumor  must  be  4  mm  maximum  and
a  small  ﬁeld  of  view  must  be  used.
• Elements  to  identify  are:
◦ localisation  of  tumor  in  relation  to  the  anal  margin
as  well  as  in  relation  to  the  peritoneal  reﬂection
line,
◦ T  and  N  staging,
◦ distance  to  the  circumferential  resection  margin,
◦ relation  with  sphincters,
◦ intravascular  extramural  extension.
linical case
 70-year-old  man  is  experiencing  rectorrhagia.  Following
n  endoscopy,  a  rectal  tumor  was  diagnosed  and  a  pelvic
RI  was  requested  to  assess  the  locoregional  extension  of
his  lesion  (Fig.  15).
uestions
.  Knowing  that  the  distance  we  can  measure  in  this  sagittal
section  (Fig.  15a)  between  the  lower  edge  of  the  tumor
and  the  anal  margin  is  10  cm,  how  would  you  situate  this
tumor?  What  anatomical  element  would  enable  you  to
deﬁne  the  highest  point  of  this  lesion?
.  How  would  you  classify  this  lesion  for  stage  T?  Justify
your  answer.
. During  multidisciplinary  meetings,  is  the  distinction
between  the  stages  T2  and  T3  fundamental  in  the  case
of  this  tumor?  Why?
.  How  would  you  evaluate  the  prognosis  of  this  tumor?
nswers
.  A  tumor  whose  lower  edge  is  10  cm  from  the  anal  margin
is  at  the  limit  of  the  upper  rectum.  However,  from  the
sagittal  section,  we  can  observe  that  the  main  part  of  the
tumor  is  located  below  the  anterior  peritoneal  reﬂection
line.  Furthermore,  in  the  axial  section,  the  lower  part  of
the  tumor  is  surrounded  by  mesorectum.  It  is  therefore
a  tumor  of  the  mid-rectum.
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[Figure 15. Sagittal (a), coronal (b) and axial perpendicular to th
2.  The  lesion  must  be  classiﬁed  as  T3.  In  fact,  in  both
the  sagittal  and  axial  sections  perpendicular  to  the
tumor,  there  is  an  area  where  the  muscular  layer  is  no
longer  visible,  with  a  discreet  tumoral  extension  into  the
mesorectal  fat.
3.  No,  the  distinction  is  not  fundamental  because  the  prog-
noses  of  a  T2  lesion  of  the  mid-rectum  and,  as  in  this
case,  of  a  T3  lesion  with  a  small  extension  into  the
mesorectum  of  less  than  1  mm,  are  similar.
4.  In  theory,  this  tumor  has  a  good  prognosis  because  it  is  a
tumor  of  the  mid-rectum  at  stage  T3  with  an  associated
extension  into  the  mesorectum  <5  mm,  a  clear  circumfer-
ential  resection  margin,  and  no  signs  of  an  intravascular
extramural  extension  or  suspicious  lymph  nodes.
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